Press-release for stocks for novartis ag for SRNE

Prices are updated after-hours

| -8.55% | O: 0.39% H: 0.82% C: -0.74%
NVS | $94.36 1.93% 0.0% 2.3M

| -12.41% | O: 0.22% H: 0.43% C: -0.39%
SRNE | $0.024 -8.85% 57K

| -33.33% | O: -63.33% H: 263.64% C: 127.27%
GILD | $66.77 0.92% 0.91% 11M

| -16.0% | O: 0.1% H: 0.43% C: -0.04%
AUTL | $4.51 -6.04% -6.43% 1.4M

| -18.12% | O: -0.91% H: 11.52% C: 4.94%
drug report t-cell global therapy market

Outlook on the CAR T-cell Therapy Global Market to 2031 - by Product Type, Indications, End-user and Region
Published: 2022-01-14 (Crawled : 14:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K

| 4.78% | O: 1.26% H: 0.0% C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M

| 4.4% | O: 0.02% H: 0.0% C: 0.0%
JNJ | News | $147.91 1.49% -0.03% 9.6M

| -12.74% | O: -0.53% H: 0.0% C: 0.0%
SRNE | $0.024 -8.85% 57K

| -99.56% | O: -5.96% H: 0.0% C: 0.0%
GILD | $66.77 0.92% 0.91% 11M

| -7.46% | O: -0.32% H: 0.0% C: 0.0%
BLUE | $1.02 7.03% 6.11% 8.2M

| -88.45% | O: -0.57% H: 0.0% C: 0.0%
cel therapy t-cell

67%

33%

Save your searches and get alerts when important news are released.